Is Estramustine covered by medical insurance? Medical insurance policies and reimbursement instructions

Estramustine (Estramustine) is a chemotherapy drug mainly used to treat malignant tumors such as prostate cancer. In China, estramustine has been approved for marketing and included in the medical insurance catalog. The specific varieties and indications included in medical insurance may vary from region to region, and patients should consult the local medical insurance department or medical institution before use.

In the Chinese mainland market, estramustine's 0.14g*40 capsules are priced at approximately 3000 RMB. Compared with overseas markets, domestic prices are relatively affordable. For example, the average price of 30Capsules of Emcyt (Estramustine) in overseas markets is approximately 514.27USD, and the average retail price after discount is 634.99USD. Calculated based on the current exchange rate, the RMB equivalent is about 3500 to 4000 yuan. Therefore, when domestic patients are reimbursed by medical insurance, the economic burden of using estramustine is relatively light.

The medical insurance reimbursement rate and scope of estramustine may vary by region. Generally speaking, patients need to hold a valid medical insurance card and a prescription issued by a doctor to go to a designated medical institution to purchase. The specific reimbursement ratio and amount should be determined according to local medical insurance policies and the patient’s medical insurance type (such as urban employee medical insurance, new rural cooperative medical insurance, etc.). It is recommended that patients consult their local medical insurance department or medical institution for detailed reimbursement policies and procedures before taking medication.

In short, estramustine has been launched in China and is included in medical insurance, and patients can enjoy medical insurance reimbursement if they meet the conditions. Specific reimbursement policies and procedures should be implemented in accordance with the regulations of the local medical insurance department. Patients should consult their doctors and medical insurance departments before taking medication to ensure medication safety and minimize economic burden.

Reference materials:https://www.drugs.com/